Asia ex-Japan, Institutional

Changechevron_right
menu
search

Health care

Showing 6 of 6 Insights Posts
1271246974
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

The role of public/private collaboration

Josh Sommerfeld, health care sector lead for late-stage private investments, highlights why he believes working with public-market colleagues like Dave Khtikian helps him be better at the four key parts of his job: sourcing, diligence, pricing, and exiting.

Continue reading
event February 2025
2 min
Video
2026-01-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1349253411
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech: Immunology and inflammation’s third wave

Our experts discuss how I&I is building on industry progress to offer new treatment solutions and interesting opportunities for private biotech investors. 

Continue reading
event December 2024
5 min
Article
2025-12-01
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
97970762
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Strong fundamentals, attractive valuations: Why the time may be right for active biotech investing

From solid fundamentals to supportive macro conditions, learn why our biotech experts believe the industry may be ready to run.

Continue reading
event October 2024
8 min
Article
2025-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
2032712798
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Biotech IPOs in 2025: Quantity, quality, and best practices

We explore today's biotech IPO market, highlighting recent market trends, key characteristics for successful biotech IPOs, and best practices to sustain momentum as a public biotechnology company.

Continue reading
event August 2024
4 min
Article
2025-08-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1413597282
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Built to last? Identifying durable health care start-ups

Two members of our late-stage growth team share insights and results from their recent analysis of enterprise-value trajectories for private, non-biotech health care companies.

Continue reading
event May 2024
14 min
Article
2025-05-23
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1387055829
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Novel therapies changing the course of health care

Several new drug classes represent a growing investment opportunity set that could reshape the health care sector.

Continue reading
event October 2023
Article
2024-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.